Risk score to assess mortality risk in patients undergoing transvenous lead extraction.

Aims: The main aim of this study was to assess 1-year mortality and its predictors in a cohort of patients who underwent transvenous lead extraction (TLE) procedure.

Methods: Retrospective analysis of clinical characteristics and 1-year follow-up of patients referred for a TLE procedure in a single, high-volume center between June 2006 and October 2014 was performed.

Results: The studied population included 130 patients (82 males; mean age 64 ± 15 years) implanted with pacemakers (74%), implantable cardioverter defibrillators (15%), or cardiac resynchronization therapy defibrillator (11%).

Parameters associated with one-year mortality and in-hospital adverse events in patients after emergency pacemaker implantation.

Background: Permanent cardiac pacing is the treatment of choice for severe and symptomatic bradycardia. Patients undergoing emergency pacemaker implantation are stabilised earlier by the insertion of a temporary emergency pacing lead, and they experience more comorbidities than with planned admissions.

Aim: To identify the parameters associated with one-year mortality and in-hospital adverse events after emergency permanent pacemaker implantation.